Ac2-26 TFA
Ac2-26 TFA, an active N-terminal peptide of annexin A1 (AnxA1), attenuates ischemia-reperfusion-induced acute lung injury. Ac2-26 also decreases AnxA1 protein expression, inhibits the activation of NF-κB and MAPK pathways in the injured lung tissue.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
———
Molecular Formula
———
Notes
Research use only, not for human use.
Receptor
Other Targets
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
396503-01 50 µL
CD45 (Receptor-Type Tyrosine-Protein Phosphatase C, Leukocyte Common Antigen, L-CA, T200, CD45, PTPRC)
Ask
View Details 
396503-02 100 µL
CD45 (Receptor-Type Tyrosine-Protein Phosphatase C, Leukocyte Common Antigen, L-CA, T200, CD45, PTPRC)
Ask
View Details MBS2003986-01 0.1 mL
Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)
Ask
View Details MBS2003986-02 0.2 mL
Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)
Ask
View Details MBS2003986-03 0.5 mL
Polyclonal Antibody to Tumor Necrosis Factor Related Apoptosis Inducing Ligand (TRAIL)
Ask
View Details